Top

Journal of Nanoparticle Research

Published in:

01-03-2011 | Research Paper

Doxorubicin delivered to MCF-7 cancer cells by superparamagnetic iron oxide nanoparticles: effects on subcellular distribution and cytotoxicity

Authors: E. Munnier, S. Cohen-Jonathan, K. Hervé, C. Linassier, M. Soucé, P. Dubois, I. Chourpa

Published in: Journal of Nanoparticle Research | Issue 3/2011

Activate our intelligent search to find suitable subject content or patents.

search-config

AI-assisted search

Off

Abstract

The clinical use of the anticancer drug doxorubicin (DOX) is limited by strong side effects and phenomena of cell resistance. Drug targeting by binding DOX to nanoparticles could overcome these limitations. We recently described a method to associate DOX to superparamagnetic iron oxide nanoparticles (SPION) in view of magnetic drug targeting (Munnier et al. in Int J Pharm 363:170–176, 2008). DOX is bound to the nanoparticle surface through a pre-formed DOX–Fe²⁺ complex. The DOX-loaded SPION present interesting properties in terms of drug loading and biological activity in vitro. The purpose of this study is to explore the possible mechanisms of the in vitro cytotoxicity of DOX-loaded SPION. The uptake of SPION was followed qualitatively by conventional optical microscopy after Prussian blue staining and quantitatively by iron determination by atomic absorption spectroscopy. The subcellular distribution of intrinsically fluorescent DOX was followed by confocal spectral imaging (CSI) and the subsequent cytotoxicity by the MTT method. We reveal modifications of DOX intracellular interactions for SPION-delivered drug and increased cytotoxicity. These results are discussed in terms of internalization route of the drug and of a potential role of iron oxide nanoparticles in the observed cytotoxicity.

previous article Tuning the number of plasmon band in silver ellipsoidal nanoshell: refractive index sensing based on plasmon blending and splitting

next article Modeling and simulation of titanium dioxide nanoparticle synthesis with finite-rate sintering in planar jets

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

inform now

Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S, Lübbe AS (2000) Locoregional cancer treatment with magnetic drug targeting. Cancer Res 60:6641–6648

Anderson AB, Gergen J, Arriaga EA (2002) Detection of doxorubicin and metabolites in cell extracts and in single cells by capillary electrophoresis with laser-induced fluorescence detection. J Chromatogr B Anal Technol Biomed Life Sci 769:97–106CrossRef

Apopa PL, Qian Y, Shao R, Lan Gua N, Schwegler-Berry N, Pacurari M, Porter D, Shi X, Vallyathan V, Castranova V, Flynn DC (2009) Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodelling. Part fibre toxicol 6:1–14CrossRef

Aroui S, Brahim S, De Waard M, Bréard J, Kenani A (2009) Efficient induction of apoptosis dy doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231. Cancer Lett 285:28–38CrossRef

Aroui S, Brahim S, Kenani A (2010) Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell penetrating peptides in different cell lines: a comparative study. BBRC. doi:10.1016/j.bbrc.2009.11.073

Auffan M, Rose J, Wiesner MR, Bottero JY (2009) Chemical stability of metallic nanoparticles: a parameter controlling their potential cellular toxicity in vitro. Environ Pollut 157:1127–1133CrossRef

Belhoussine R, Morjani H, Millot JM, Sharonov S, Manfait M (1998) Microspectrofluorometry reveals specific anthracycline accumulation in cytoplasmic organelles of multidrug-resistant cancer cells. J Histochem Cytochem 46:1369–1376

Choi SJ, Oh JM, Choy JH (2009) Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J Inorg Biochem 103:463–471CrossRef

Chourpa I, Douziech-Eyrolles L, Ngaboni Okassa L, Fouquenet JF, Cohen-Jonathan S, Soucé M, Marchais H, Dubois P (2005) Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy. Analyst 130:1395–1403CrossRef

Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422:37–44CrossRef

del Pozo-Rodríguez A, Pujals S, Delgado D, Solinís MA, Gascón AR, Giralt E, Pedraz JL (2009) A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors. J Control Release 133:52–59CrossRef

Demaurex N, Grinstein S (2006) Measurements of endosomal pH in live cells by dual excitation fluorescence imaging. In: Cell Biol, 3rd edn. pp 163–169

Donaldson K, Stone V, Clouter A, Renwick L, MacNee W (2001) Ultrafine particles. Occup Environ Med 58:211–216

Douziech-Eyrolles L, Marchais H, Hervé K, Munnier E, Soucé M, Linassier C, Dubois P, Chourpa I (2007) Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles. Int J Nanomed 2(4):541–550

Ebbesen P, Pettersen EO, Gorr TA, Jobst G, Williams K, Kieninger J, Wenger RH, Pastorekova S, Dubois L, Lambin P, Wouters BG, Van Den Beucken T, Supuran CT, Poellinger L, Ratcliffe P, Kanopka A, Görlach A, Gasmann M, Harris AL, Maxwell P, Scozzafava A (2009) Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies. J Enzyme Inhibit Med Chem 24(1):1–39

Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdörster G, McGrath JL (2009) The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 30:603–610CrossRef

Engin K, Leeper DB, Cater JR, Thistlethwaite AJ, Tupchong L, McFarlane JD (1995) Extracellular pH distribution in human tumors. Int J Hypertherm 11:211–216CrossRef

Fiallo MML, Garnier-Suillerot A, Matzanke B, Kozlowski H (1999) How Fe³⁺ binds anthracycline antitumour compounds. The myth and the reality of a chemical sphinx. J Inorg Biochem 75:105–115CrossRef

Gabrielson NP, Pack DW (2009) Efficient polyethylenimine-mediated gene delivery proceeds via a caveolar pathway in HeLa cells. J Control Release 136:54–61CrossRef

Gallois L, Fiallo M, Laigle A, Priebe W, Garnier-Suillerot A (1996) The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids. Eur J Biochem 241:879–887CrossRef

Ge Y, Zhang Y, Xia J, He S, Nie F, Gu N (2009) Effect of surface charge and agglomerate degree of magnetic iron nanoparticles on KB cellular uptake in vitro. Colloid Surf B Biointerfaces 73:294–301CrossRef

Glait C, Ravid D, Lee SW, Liscovitch M, Werner H (2006) Caveolin-1 controls BRCA1 gene expression and cellular localization in human breast cancer cells. FEBS Lett 580:5268–5274CrossRef

Gumbleton M, Hollins AJ, Omidi Y, Campbell L, Taylor G (2003) Targeting caveolae for vesicular drug transport. J control release 87:139–151CrossRef

Hande KR (2006) Topoisomerase II inhibitors. Update Cancer Therap 1:3–15CrossRef

Hovorka O, St’astny M, Etrych T, Subr V, Strohalm J, Ulbrich K, Rihova B (2002) Differences in the intracellular fate of free and polymer-bound doxorubicin. J Control Release 80:101–117

Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V (2005) Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm 2:194–205CrossRef

Jing Y, Naladri M, Williams PS, Mayorga M, Penn MS, Chalmers JJ, Zborowski M (2008) Quantitative intracellular magnetic nanoparticles uptake measured by live cell magnetophoresis. FASEB J 22:4239–4247CrossRef

Jones CF, Grainger DW (2009) In vitro assessments of nanomaterial toxicity. Adv Drug Deliv Rev 61:438–456CrossRef

Karlsson HL, Cronholm P, Gustafsson J, Möller L (2008) Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 21:1726–1732CrossRef

Karukstis K, Thompson EHZ, Whiles JA, Rosenfeld RJ (1998) Deciphering the fluorescence signature of daunomycin and doxorubicin. Biophys Chem 73:249–263CrossRef

Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kwon GS (2000) Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Control Release 64:143–153CrossRef

Leonard RCF, Williams S, Tulpule A, Levine AM, Oliveros S (2009) Improving the therapeutic index of anthracyclines chemotherapy: focus on liposomal doxorubicin (Myocet^®). Breast 18:218–224CrossRef

Lewinski N, Colvin V, Drezek R (2008) Cytotoxicity of nanoparticles. Small 4(1):26–49CrossRef

Lübbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K, Matthias M, Dorken B, Herrmann F, Gurtler R, Hohenberger P, Haas N, Sohr R, Sander B, Lemke AJ, Ohlendorf D, Huhnt W, Huhn D (1996) Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 56:4686–4693

Mahmoudi M, Simchi A, Imani M, Shokrgozar MA, Milani AS, Häfeli UO, Troeve P (2009) A new approach for the in vitro identification of the cytotoxicity of Superparamagnetic iron oxide nanoparticles. Colloid Surf B Biointerfaces 75:300–309CrossRef

Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229CrossRef

Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63CrossRef

Mudhakir D, Akita H, Tan E, Harashima H (2008) A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway. J Control Release 125(2):164–173CrossRef

Munnier E, Tewes F, Cohen-Jonathan S, Linassier C, Douziech-Eyrolles L, Marchais H, Soucé M, Hervé K, Dubois P, Chourpa I (2007) On the interaction of doxorubicin with oleate ions: fluorescence spectroscopy and liquid-liquid extraction study. Chem Pharm Bull 55:1006–1010CrossRef

Munnier E, Cohen-Jonathan S, Linassier C, Douziech-Eyrolles L, Marchais H, Soucé M, Hervé K, Dubois P, Chourpa I (2008) Novel method of doxorubicin—SPION reversible association for magnetic drug targeting. Int J Pharm 363:170–176CrossRef

Mykhaylyk O, Dudchenko N, Dudchenko A (2005) Doxorubicin magnetic conjugate targeting upon intravenous injection into mice: high gradient magnetic field inhibits the clearance of nanoparticles from the blood. J Magn Magn Mater 293:473–482CrossRef

Pelkmans L, Helenius A (2003) Insider information: what viruses tell us about endocytosis. Curr Opin Cell Biol 15:414–422CrossRef

Pradhan P, Giri J, Banerjee R, Bellare J, Bahadur D (2007) Cellular interactions of lauric acid and dextran-coated magnetite nanoparticles. J Magn Magn Mater 311:282–287CrossRef

Pütz G, Schmah O, Eckes J, Hug MJ, Winkler K (2009) Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapy. Med Hypothesis doi:10.1016/j.mehy.2008.11.027

Raghunand N, Mahoney BP, Gillies RJ (2003) Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol 66:1219–1229CrossRef

Razzano G, Rizzo V, Vigevani A (1990) Determination of phenolic ionization constants of anthracyclines with modified substitution pattern of anthraquinone chromophore. IL Farmaco 45:215–222

Rudge SR, Kurtz TL, Vessely CR, Catterall LG, Williamson DL (2000) Preparation, characterization, and performance of magnetic iron-carbon composite microparticles for chemotherapy. Biomaterials 21:1411–1420CrossRef

Schöpf B, Neuberger T, Schulze K, Petri A, Chastellain M, Hoffmann M, Hoffmann H, von Rechenberg B (2005) Methodology description of cellular uptake of PVA coated superparamagnetic iron oxide nanoparticles (SPION) in synovial cells of sheep. J Magn Magn Mater 293:411–418CrossRef

Sharonov S, Chourpa I, Morjani H, Nabiev I, Manfait M, Feofanov A (1994) Confocal spectral imaging analysis in studies of the spatial distribution of antitumor drugs within living cancer cells. Anal Chim Acta 290:40–47CrossRef

Shen Y, Tang H, Zhan Y, Van Kirk EA, Murdoch WJ (2009) Degradable poly(β-amino ester) nanoparticles for cancer cytoplasmic drug delivery. Nanomedicine doi:10.1016/j.nano.2008.09.003

Vibet S, Mahéo K, Goré J, Dubois P, Bougnoux P, Chourpa I (2007) Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines. Drug Metab Disp 35:822–828CrossRef

Vieseh O, Gunn J, Zhang M (2009) Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv drug deliv rev. doi:10.1016/j.addr.2009.11.002

Wilhelm C, Gazeau F (2008) Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 29:3161–3174CrossRef

Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F (2003) Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24:1001–1011CrossRef

Xiong XB, Ma Z, Lai R, Lavasanifar A (2010) The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Biomaterials 31:757–768CrossRef

Zhang J, Misra RDK (2007) Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticles carrier and drug release response. Acta Biomater 3:838–850CrossRef

Zhang Y, Yang M, Portney NG, Cui D, Budak G, Ozbay E, Ozkan M, Ozkan CS (2008) Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells. Biomed Microdevices 10:321–328CrossRef

Zhang X, Meng L, Lu Q, Fei Z, Dyson P (2009) Targeted and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials 30:6041–6047CrossRef

Title: Doxorubicin delivered to MCF-7 cancer cells by superparamagnetic iron oxide nanoparticles: effects on subcellular distribution and cytotoxicity
Authors: E. Munnier
S. Cohen-Jonathan
K. Hervé
C. Linassier
M. Soucé
P. Dubois
I. Chourpa
Publication date: 01-03-2011
Publisher: Springer Netherlands
Published in: Journal of Nanoparticle Research / Issue 3/2011
Print ISSN: 1388-0764
Electronic ISSN: 1572-896X
DOI: https://doi.org/10.1007/s11051-010-0093-1

Springer Professional

Abstract

Please log in to get access to your license.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Other articles of this Issue 3/2011

Synthesis of nanocrystalline cubic zirconia using femtosecond laser ablation

Controlled release of ketorolac through nanocomposite films of hydrogel and LDH nanoparticles

Thermostable photocatalytically active TiO2 anatase nanoparticles

Silica-modified Fe-doped calcium sulfide nanoparticles for in vitro and in vivo cancer hyperthermia

Generation of reactive oxygen species and oxidative stress in Escherichia coli and Staphylococcus aureus by a novel semiconductor catalyst

Nanoparticles dispersion in processing functionalised PP/TiO2 nanocomposites: distribution and properties

Premium Partners